You are here: Home » News-ANI » Health
Business Standard

Common diabetes pill might increase heart disease risk

ANI  |  Washington 

A new study has claimed that a common diabetes pill can radically raise the risk of heart disease and other complications.

The study suggested that metformin, which is used to treat Type 2 diabetes, can increase the risk of people with an underactive thyroid suffering from low thyroid-stimulating hormone (TSH) levels.

The researchers surveyed 74,300 patients who received metformin and sulfonylurea, another common diabetes drug, over a 25-year period where 5,689 had treated hypothyroidism, and 59,937 had normal thyroid function.

The study demonstrated that in the group with hypothyroidism, there were 495 incidences of low thyroid-stimulating hormone (119.7 per 1000) per year compared with 322 in the normal group (4.5 per 1000).

Researcher Dr. Laurent Azoulay, from McGill University in Montreal, Canada, said that the results of this longitudinal study confirmed that the use of metformin was associated with an increased risk of low TSH levels in patients with treated hypothyroidism.

Azoulay added that given the relatively high incidence of low TSH levels in patients taking metformin, it was imperative that future studies assessed the clinical consequences of this effect.

The research is published in CMAJ (Canadian Medical Association Journal).

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, September 23 2014. 12:26 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU